Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants - The Lancet

Trends in hypertension prevalence, awareness, treatment, and control in South Korea, 1998–2021: a nationally representative serial study

Modeling global 80-80-80 blood pressure targets and cardiovascular outcomes

Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey

More than 700 million people with untreated hypertension

A comparison study of prevalence, awareness, treatment and control rates of hypertension and associated factors among adults in China and the United States based on national survey data - ScienceDirect

Pharmacotherapy for Essential Hypertension: A Brief Review - Methodist DeBakey Cardiovascular J

JCDD, Free Full-Text

A comparison study of prevalence, awareness, treatment and control rates of hypertension and associated factors among adults in China and the United States based on national survey data - ScienceDirect

JKMS :: Journal of Korean Medical Science

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants - The Lancet

Association of lipid accumulation product and visceral adiposity index with the risk of hypertension among oil workers in Xinjiang, China [PeerJ]

Four questions for Prof. Dr. Reinhold Kreutz, President of the European Society of Hypertension (ESH)

Prevalence, awareness, treatment, and control of hypertension in China, 2004-18: findings from six rounds of a national survey

The prevalence, disability-adjusted life years, and mortality of hypertensive heart disease and its attributable risk factors: results from the Global Burden Disease study 2019